MONTVALE, N.J., Aug. 2 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) announced today that it will report its second quarter
2006 financial results on Wednesday, August 9, 2006, before the U.S. financial
markets open. Management will provide a Company update and discuss the second
quarter results during a conference call on Wednesday, August 9, 2006, at 9:00
a.m. EDT.
Investors and other interested parties may access the call as follows:
Date: Wednesday, August 9, 2006
Time: 9:00 a.m. EDT
Telephone (U.S.): 866.800.8649
Telephone (international): 617.614.2703
Participant Passcode: 94294745
Webcast: http://www.memorypharma.com under the
"Investors" section
An audio replay of the conference call will be available from 11:00 a.m.
EDT on Wednesday, August 9, 2006, until Wednesday, August 16, 2006. To access
the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international)
and enter pass code number 63605504. An audio replay of the conference call
will also be available under the "Investors" section of the Company's website
during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 08/02/2006
/CONTACT: Jzaneen Lalani, Vice President, Legal Affairs, +1-201-802-7249;
or Laura Perry of Stern Investor Relations, Inc., +1-212-362-1200/
/Web site: http://www.memorypharma.com /
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: BIO HEA MTC
SU: CCA
JC
-- NYW146 --
4753 08/02/2006 16:05 EDT http://www.prnewswire.com
